Figure 11 | Scientific Reports

Figure 11

From: Multi-omics reveals the role of ENO1 in bladder cancer and constructs an epithelial-related prognostic model to predict prognosis and efficacy

Figure 11

The nomogram was more precise in predicting the prognosis of BLCA patients than other signatures. (A) The prognostic nomogram constructed based on the risk score and clinicopathological parameters predicted the survival rate of TCGA-BLCA patients at 1, 3, and 5 years. (B) Calibration curves showing the concordance between predicted and observed 1-, 3-, and 5-year survival rates. AUCs of the nomogram, risk score and other signatures in ROC analysis were calculated at (C) 1-, (D) 3-, and (E) 5-year OS times in the TCGA-BLCA cohort. Decision curve analyses (DCA) for the nomogram, EETS and other signatures at (F) 1, (G) 3, and (H) 5 years to assess clinical utility in the TCGA-BLCA cohort.

Back to article page